Table 2 Historical and predicted drug expenditures for 2010 and 2011 in different therapeutic areas.
From: Forecasting drug utilization and expenditure in a metropolitan health region
ATC | Therapeutic area | Expenditures | Forecast | Change 2010 | Change 2011 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Â | Â | 2007 | 2008 | 2009 | 2010 | 2011 | MSEK | (%) | MSEK | (%) |
A02 | Drugs for acid related disorders | 143 | 124 | 113 | 107 | 104 | -5 | -5% | -3 | -3% |
A10 | Drugs for diabetes | 194 | 209 | 214 | 223 | 231 | 9 | 4% | 8 | 4% |
A | Other therapeutic areas | 286 | 286 | 287 | 280 | 293 | -7 | -2% | 13 | 5% |
B01 | Anticoagulants | 164 | 180 | 189 | 173 | 202 | -16 | -9% | 29 | 17% |
B02 | Coagulation factors | 197 | 212 | 225 | 238 | 249 | 12 | 5% | 12 | 5% |
B | Other therapeutic areas | 267 | 269 | 268 | 267 | 266 | -1 | 0% | -1 | 0% |
C09C&D | Angiotensin receptor blockers | 185 | 199 | 204 | 157 | 138 | -47 | -23% | -19 | -12% |
C10 | Lipid lowering agents | 145 | 149 | 140 | 131 | 131 | -9 | -6% | 0 | 0% |
C | Other therapeutic areas | 323 | 305 | 301 | 286 | 287 | -14 | -5% | 1 | 0% |
D | Dermatologicals | 161 | 168 | 174 | 177 | 181 | 3 | 2% | 4 | 2% |
G | Genito Urinary system | 374 | 382 | 380 | 388 | 401 | 8 | 2% | 13 | 3% |
H | Hormones | 173 | 179 | 186 | 188 | 192 | 2 | 1% | 4 | 2% |
J01 | Antibiotics | 230 | 243 | 250 | 248 | 250 | -2 | -1% | 2 | 1% |
J05 | Antiviral drugs | 205 | 233 | 270 | 294 | 322 | 24 | 9% | 28 | 10% |
J | Other therapeutic areas | 146 | 151 | 154 | 166 | 175 | 13 | 8% | 9 | 5% |
L01 & L02 | Oncology | 521 | 584 | 592 | 591 | 583 | -1 | 0% | -8 | -1% |
L04AB | TNF - alpha inhibitors | 304 | 359 | 420 | 473 | 529 | 53 | 13% | 56 | 12% |
L | Other therapeutic areas | 274 | 328 | 366 | 386 | 415 | 20 | 5% | 29 | 7% |
M | Musculo-skeletal system | 194 | 198 | 185 | 187 | 180 | 2 | 1% | -7 | -4% |
N02A&B | Analgesics | 165 | 176 | 189 | 199 | 209 | 10 | 5% | 11 | 5% |
N03 | Antiepileptics | 122 | 142 | 149 | 157 | 165 | 8 | 5% | 7 | 5% |
N05A | Antipsychotics | 166 | 177 | 175 | 171 | 167 | -4 | -2% | -4 | -2% |
N06A | Antidepressants | 191 | 187 | 135 | 127 | 127 | -8 | -6% | 0 | 0% |
N | Other therapeutic areas | 440 | 481 | 522 | 567 | 619 | 44 | 9% | 52 | 9% |
P | Antiparasitic products | 17 | 16 | 15 | 15 | 15 | 0 | -1% | 0 | -3% |
R | Respiratory system | 477 | 504 | 539 | 565 | 596 | 26 | 5% | 30 | 5% |
S | Sensory organs | 123 | 138 | 148 | 154 | 160 | 6 | 4% | 6 | 4% |
V | Various | 116 | 125 | 130 | 140 | 148 | 10 | 8% | 8 | 6% |
A-V | ALL DRUGS | 6 304 | 6 702 | 6 921 | 7 056 | 7 336 | 135 | 2% | 280 | 4% |